Maharashtra FDA cancels drug distribution licences over packaging and storage violations

The Maharashtra FDA has cancelled the drug sale and distribution licences of a major pharmaceutical manufacturer’s Pune warehouse over violations involving packaging, storage, documentation and recall requirements. The action highlights increased scrutiny of supply-chain compliance and reinforces that regulatory obligations extend beyond manufacturing to warehousing and distribution.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.